BioSpace News Archive

NOXXON ANNOUNCES KEY FINDINGS THAT NOX-A12 PLUS KEYTRUDA® INDUCES AN IMMUNE RESPONSE AND RESULTS IN CLINICAL BENEFIT FOR PATIENTS

Findings include stable disease and prolonged time on treatment vs. prior therapy in heavily pretreated metastatic pancreatic and colorectal cancer patients

December 16, 2018
·
4 min read
Policy

Fidelta announces drug discovery agreement with Galapagos

Fidelta Ltd is pleased to announce that it has signed an integrated drug discovery agreement with Galapagos based on Fidelta’s macrocyclic platform.

December 16, 2018
·
2 min read
LDC and the University of Duisburg-Essen receive EUR 905,000 for the development of new therapies for age-related blindness

The Lead Discovery Center GmbH (LDC) and the University of Duisburg-Essen (UDE) have received EUR 905,000 in funding from the state of North Rhine-Westphalia as part of its lead market competition, LifeSciences.NRW.

December 16, 2018
·
3 min read
Deals

NOXXON ANNOUNCES TRADING HALT ON EURONEXT GROWTH PARIS AHEAD OF TRIAL DATA PUBLICATION AT THE ESMO IMMUNO-ONCOLOGY CONGRESS

NOXXON Pharma N.V., announced its decision to suspend trading on Friday, December 14, 2018.

December 16, 2018
·
2 min read
Drug Development

VAXIMM Initiates Phase I/II Trial with VXM01 Oral T-cell Immunotherapy in Combination with PD-L1 Inhibitor Avelumab in Glioblastoma

VAXIMM AG, announced that the first patient has been dosed in a Phase I/II trial evaluating VXM01 oral immunotherapy in combination with avelumab*, a human anti-PD-L1 antibody, for the treatment of glioblastoma.

December 16, 2018
·
7 min read
Business

QuantuMDx Group Limited and Molbio Diagnostics announce a Memorandum of Understanding at FutureTech Festival

QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working in infectious disease diagnostics, with an initial focus on genotypic drug resistance testing for those infected with tuberculosis.

December 16, 2018
·
4 min read
Business

Rentschler Biopharma SE appoints Biopharmaceutical Development Expert Dr. Jesús Zurdo as Senior Vice President Process Science and Innovation

Rentschler Biopharma SE, announced that Dr. Jesús Zurdo will join the company as Senior Vice President Process Science and Innovation, effective January 01, 2019.

December 16, 2018
·
3 min read
Policy

Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School

Axovant Sciences, announced that it has licensed exclusive worldwide rights for the development and commercialization of two novel gene therapy programs to address GM1 gangliosidosis and GM2 gangliosidosis from the University of Massachusetts (UMass) Medical School.

December 16, 2018
·
10 min read
Business

Alexandria LaunchLabs, the Premier Platform Accelerating Early-Stage Life Science Company Growth, Opens First Cambridge Location at the Alexandria Center at One Kendall Square

Cambridge provides member companies with a unique, full-service platform featuring highly flexible, cost-effective, move‑in‑ready and well-equipped wet laboratory and office space; strategic programming and mentoring; and access to seed capital through the Alexandria Seed Capital Platform

December 16, 2018
·
7 min read
Daicel-Evonik’s PEEK VESTAKEEPⓇ Care Sizing tools for cervical spine surgery

PEEK resin VESTAKEEPⓇ Care* from Evonik Resource Efficiency GmbH Performance Foams and Daicel-Evonik Ltd., has been adopted as a sizing jig for pedestoplasty at Ammtec Co., Ltd.

December 16, 2018
·
4 min read